Keith Crandell, Director, 10% Owner at Twist Bioscience Corp (TWST), bought 1,257,645 shares at $14.00 ($1.1M) on 2018-11-02, disclosed to the SEC on 2018-11-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,182,645 | $0 | 0.0% |
| 2 | $14.00 | 15,000 | $210K | 20.0% |
| 3 | $14.00 | 60,000 | $840K | 80.0% |
| Total | $0.83 avg | 1,257,645 | $1.1M | 100% |
| Filing → |
| DALS | BUY | 2021-08-03 | $16.0M | — | Filing → |
| MASS | BUY | 2020-12-22 | $6.0M | — | Filing → |
| TWST | SELL | 2020-12-09 | $15.5M | — | Filing → |